Geopolitical tensions, rising costs, and regulatory requirements are presenting new challenges for the pharmaceutical supply chain.
👉 Our CEO Sandra Hartbach contributed to this year’s CPHI Pharma Trends Outlook Report, highlighting the key areas of tension: While other regions are pushing their strategies forward with greater determination, Europe often lacks a unified approach.
💡 Takeaway: Resilience does not come from complete localization. What is needed is a balanced strategy that specifically strengthens regional capacities while also emphasizing geographically diversified value chains. Only in this way can costs, supply security, and regulatory requirements be sustainably reconciled.
📄 Read more in the full report.
DREHM Pharma. Sharing Experience. 🌐
